Literature DB >> 10782059

Tryptophan degradation to control T-cell responsiveness.

B Widner, G Weiss, D Fuchs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10782059     DOI： 10.1016/s0167-5699(00)01616-9

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  5 in total

1.  Relationship between indoleamine 2,3-dioxygenase activity and lymphatic invasion propensity of colorectal carcinoma.

Authors:  Atilla Engin; Ipek Isik Gonul; Ayse Basak Engin; Ahmet Karamercan; Aylin Sepici Dincel; Ayse Dursun
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

2.  Atorvastatin suppresses interferon-gamma -induced neopterin formation and tryptophan degradation in human peripheral blood mononuclear cells and in monocytic cell lines.

Authors:  G Neurauter; B Wirleitner; A Laich; H Schennach; G Weiss; D Fuchs
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

3.  Picolinic acid in patients with chronic hepatitis C infection: a preliminary report.

Authors:  Jolanta Zuwała-Jagiello; Monika Pazgan-Simon; Krzysztof Simon; Maria Warwas
Journal:  Mediators Inflamm       Date:  2012-04-10       Impact factor: 4.711

4.  Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

Authors:  Guido Frumento; Rita Rotondo; Michela Tonetti; Gianluca Damonte; Umberto Benatti; Giovanni Battista Ferrara
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

Review 5.  Immune metabolism in PD-1 blockade-based cancer immunotherapy.

Authors:  Alok Kumar; Kenji Chamoto
Journal:  Int Immunol       Date:  2021-01-01       Impact factor: 4.823
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.